Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
This two-day meeting offers a comprehensive overview of key updates from the Summer Congresses, with a focus on how emerging data and developments are expected to influence haematology practice in the UK. Designed for consultants, nurses, pharmacists, trainees and AHPs, this event brings together leading voices in the field to deliver expert insights across a broad range of haematological conditions.
Programme highlights include:
Day 1 – Tuesday 1 July:
Myeloma updates including newly diagnosed treatment approaches, MRD/risk stratification, and bispecific/CAR-T therapy
Red cell haematology sessions on sickle cell disease, MPN/CML, and myelofibrosis
Acute leukaemia focus covering ALL, CAR-T, AML updates, and patient eligibility discussions
Industry-led satellite symposia and a networking reception
Day 2 – Wednesday 2 July:
Summary and forward-looking insights from expert chairs
Advances in lymphoma diagnostics, T-cell lymphoma, follicular and non-follicular indolent lymphomas
Treatment options for relapsed/refractory DLBCL
Sessions on Hodgkin lymphoma, aggressive B-cell lymphomas, and CLL (post-EHA updates)
–
